IGC Pharma, Inc. — Director's Dealing 2016

Dec 20, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2016-12-16

Reporting Person: PRINS RICHARD K (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-14	Common stock	G	2000	—	Disposed	249000	Direct
2016-11-18	Common stock	G	2000	—	Disposed	247000	Direct
2016-11-25	Common stock	G	2000	—	Disposed	245000	Direct
2016-12-02	Common stock	G	2000	—	Disposed	243000	Direct
2016-12-09	Common stock	G	2000	—	Disposed	241000	Direct
2016-12-15	Common stock	A	150000	—	Acquired	391000	Direct
2016-12-16	Common stock	G	2000	—	Disposed	389000	Direct

Footnotes

F1: Represents shares of Common Stock awarded pursuant to the Issuer's 2008 Omnibus Incentive Plan.